SK Biopharmaceuticals Co., Ltd et al v. Aurobindo Pharma Limited et al
| SK Biopharmaceuticals Co., Ltd. and SK Life Science, Inc. |
| Aurobindo Pharma Limited, Aurobindo Pharma U.S.A., Inc. and Zenara Pharma Pvt. Limited |
| SK Biopharmaceuticals Co., Ltd. and SK Life Science, Inc. |
| Aurobindo Pharma Limited and Aurobindo Pharma U.S.A., Inc. |
| 1:2024cv00718 |
| June 18, 2024 |
| U.S. District Court for the District of Delaware |
| Jennifer L Hall |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 271 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on August 16, 2024. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 17 Pro Hac Vice Fee - Credit Card Payment received for William D. Hare. ( re #16 MOTION for Pro Hac Vice Appearance of Attorney William D. Hare )( Payment of $ 50, receipt number ADEDC-4477823).(Dorsney, Kenneth) |
| Filing 16 MOTION for Pro Hac Vice Appearance of Attorney William D. Hare - filed by Aurobindo Pharma Limited, Aurobindo Pharma U.S.A., Inc.. (Dorsney, Kenneth) |
| Filing 15 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Aurobindo Pharma Limited for Aurobindo Pharma U.S.A., Inc. filed by Aurobindo Pharma Limited, Aurobindo Pharma U.S.A., Inc.. (Dorsney, Kenneth) |
| Filing 14 ANSWER to #1 Complaint, , COUNTERCLAIM against SK Biopharmaceuticals Co., Ltd., SK Life Science, Inc. by Aurobindo Pharma U.S.A., Inc., Aurobindo Pharma Limited.(Dorsney, Kenneth) |
| Pro Hac Vice Attorney Yixin H. Tang for Zenara Pharma Pvt. Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (oam) |
| Filing 13 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Zenara Pharma Pvt. Limited. (Gattuso, Dominick) |
| Filing 12 Pro Hac Vice Fee - Credit Card Payment received for Shashank Upadhye, Yixin Tang, and Brent Batzer. ( re #11 MOTION for Pro Hac Vice Appearance of Attorney Shashank Upadhye, Yixin Tang, and Brent Batzer of Upadhye Tang LLP )( Payment of $ 150, receipt number ADEDC-4442192).(Gattuso, Dominick) |
| Filing 11 MOTION for Pro Hac Vice Appearance of Attorney Shashank Upadhye, Yixin Tang, and Brent Batzer of Upadhye Tang LLP - filed by Zenara Pharma Pvt. Limited. (Gattuso, Dominick) |
| Pro Hac Vice Attorney Brent A. Batzer, Shashank S. Upadhye for Zenara Pharma Pvt. Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (cdd) |
SO ORDERED, re #11 Motion for Pro Hac Vice Appearance of Attorney Shashank Upadhye, Yixin Tang, and Brent Batzer of Upadhye Tang LLP filed by Zenara Pharma Pvt. Limited. Ordered by Judge Jennifer L. Hall on 7/1/2024. (ceg)
|
| Case Assigned to Judge Jennifer L. Hall. Please include the initials of the Judge (JLH) after the case number on all documents filed. (rjb) |
| Filing 10 WAIVER OF SERVICE returned executed by SK Life Science, Inc., SK Biopharmaceuticals Co., Ltd.: For Zenara Pharma Pvt. Limited waiver sent on 6/21/2024, answer due 8/20/2024. (Dellinger, Megan) |
| Filing 9 WAIVER OF SERVICE returned executed by SK Life Science, Inc., SK Biopharmaceuticals Co., Ltd.: For Aurobindo Pharma U.S.A., Inc. waiver sent on 6/20/2024, answer due 8/19/2024. (Dellinger, Megan) |
| Filing 8 WAIVER OF SERVICE returned executed by SK Life Science, Inc., SK Biopharmaceuticals Co., Ltd.: For Aurobindo Pharma Limited waiver sent on 6/20/2024, answer due 8/19/2024. (Dellinger, Megan) |
| Filing 7 Summons Issued as to Aurobindo Pharma Limited on 6/18/2024; Aurobindo Pharma U.S.A., Inc. on 6/18/2024; Zenara Pharma Pvt. Limited on 6/18/2024. (Attachments: #1 Summons Issued, #2 Summons Issued)(mrr) |
| Filing 6 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent SK Biopharmaceuticals Co., Ltd. for SK Life Science, Inc.; Corporate Parent SK Inc. for SK Biopharmaceuticals Co., Ltd filed by SK Biopharmaceuticals Co., Ltd, SK Life Science, Inc. (mrr) |
| Filing 5 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,598,279 B2; 11,654,133 B2. (mrr) |
| Filing 4 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) (Zenara) - Date Patentee(s) Received Notice: 05/13/2024. Date of Expiration of U.S. Patent No. 7,598,279: 10/30/2032, Date of Expiration of U.S. Patent No. 11,654,133: 06/16/2039, Thirty Month Stay Deadline: 9/10/2027. (mrr) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) (Aurobindo) - Date Patentee(s) Received Notice: May 7, 2024. Date of Expiration of Patent: June 16, 2039.Thirty Month Stay Deadline: 9/10/2027. (mrr) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mrr) |
| Filing 1 COMPLAINT for ANDA/PATENT INFRINGEMENT filed against Aurobindo Pharma Limited, Aurobindo Pharma U.S.A., Inc., Zenara Pharma Pvt. Limited (Filing fee $ 405, receipt number ADEDC-4432893.) - filed by SK Life Science, Inc., SK Biopharmaceuticals Co., Ltd. (Attachments: #1 Exhibit A-C, #2 Civil Cover Sheet)(mrr) |
Access additional case information on PACER
Use the links below to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
